Tissue dynamics spectroscopy for phenotypic profiling of drug effects in three-dimensional culture

Biomedical Optics Express

Volumn 3, Issue 11, 2012, Pages 2825-2841

  Nolte, David D ^a   An, Ran ^a   Turek, John ^b   Jeong, Kwan ^c  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Dept of Physics   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMICS; SIMULATED ANNEALING; TISSUE;

CELLULAR DYNAMICS; DRUG EFFECTS; DRUG SCREENING; ENVIRONMENTAL PERTURBATIONS; FEATURE VECTORS; HIGH-DIMENSIONAL; MULTI-DIMENSIONAL SCALING; MULTICELLULAR TUMOR SPHEROIDS; PHYSIOLOGICAL RESPONSE; SPECKLE FLUCTUATIONS; SPECTROGRAMS; SUB-CELLULAR; THREE-DIMENSIONAL CULTURE; TISSUE RESPONSE;

PHYSIOLOGICAL MODELS;

EID: 84869117683     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.3.002825     Document Type: Article

References (71)

1. Y. Feng, T. J. Mitchison, A. Bender, D. W. Young, and J. A. Tallarico, "Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds, " Nat. Rev. Drug Discov. 8(7), 567-578 (2009).
2. P. J. Keller, F. Pampaloni, and E. H. K. Stelzer, "Life sciences require the third dimension, " Curr. Opin. Cell Biol. 18(1), 117-124 (2006).
3. F. Pampaloni, E. G. Reynaud, and E. H. K. Stelzer, "The third dimension bridges the gap between cell culture and live tissue, " Nat. Rev. Mol. Cell Biol. 8(10), 839-845 (2007).
4. L. Gaedtke, L. Thoenes, C. Culmsee, B. Mayer, and E. Wagner, "Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells, " J. Proteome Res. 6(11), 4111-4118 (2007).
5. J. Poland, P. Sinha, A. Siegert, M. Schnölzer, U. Korf, and S. Hauptmann, "Comparison of protein expression profiles between monolayer and spheroid cell culture of HT-29 cells revealed fragmentation of CK18 in threedimensional cell culture, " Electrophoresis 23(7-8), 1174-1184 (2002).
6. T. T. Chang and M. Hughes-Fulford, "Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes, " Tissue Eng. Part A 15(3), 559-567 (2009).
7. N. A. L. Cody, M. Zietarska, A. Filali-Mouhim, D. M. Provencher, A. M. Mes-Masson, and P. N. Tonin, "Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines, " BMC Med. Genomics 1(1), 34 (2008).
8. K. Dardousis, C. Voolstra, M. Roengvoraphoj, A. Sekandarzad, S. Mesghenna, J. Winkler, Y. Ko, J. Hescheler, and A. Sachinidis, "Identification of differentially expressed genes involved in the formation of multicellular tumor spheroids by HT-29 colon carcinoma cells, " Mol. Ther. 15(1), 94-102 (2007).
9. L. David, V. Dulong, D. Le Cerf, L. Cazin, M. Lamacz, and J. P. Vannier, "Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of anticancer drug sensitivity, " Acta Biomater. 4(2), 256-263 (2008).
10. I. Serebriiskii, R. Castelló-Cros, A. Lamb, E. A. Golemis, and E. Cukierman, "Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells, " Matrix Biol. 27(6), 573-585 (2008).
11. A. Frankel, R. Buckman, and R. S. Kerbel, "Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids, " Cancer Res. 57(12), 2388-2393 (1997).
12. L. A. Hazlehurst, T. H. Landowski, and W. S. Dalton, "Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death, " Oncogene 22(47), 7396-7402 (2003).
13. J. Friedrich, W. Eder, J. Castaneda, M. Doss, E. Huber, R. Ebner, and L. A. Kunz-Schughart, "A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay, " J. Biomol. Screen. 12(7), 925-937 (2007).
14. W. Mueller-Klieser, "Three-dimensional cell cultures: from molecular mechanisms to clinical applications, " Am. J. Physiol. 273(4 Pt 1), C1109-C1123 (1997).
15. A. Frankel, S. Man, P. Elliott, J. Adams, and R. S. Kerbel, "Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341, " Clin. Cancer Res. 6(9), 3719-3728 (2000).
16. D. Barbone, T. M. Yang, J. R. Morgan, G. Gaudino, and V. C. Broaddus, "Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids, " J. Biol. Chem. 283(19), 13021-13030 (2008).
17. J. S. Eshleman, B. L. Carlson, A. C. Mladek, B. D. Kastner, K. L. Shide, and J. N. Sarkaria, "Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy, " Cancer Res. 62(24), 7291-7297 (2002).
18. A. L. Howes, G. G. Chiang, E. S. Lang, C. B. Ho, G. Powis, K. Vuori, and R. T. Abraham, "The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in threedimensional cultures, " Mol. Cancer Ther. 6(9), 2505-2514 (2007).
19. K. Jeong, L. Peng, D. D. Nolte, and M. R. Melloch, "Fourier-domain holography in photorefractive quantumwell films, " Appl. Opt. 43(19), 3802-3811 (2004).
20. P. Yu, L. Peng, M. Mustata, J. J. Turek, M. R. Melloch, and D. D. Nolte, "Time-dependent speckle in holographic optical coherence imaging and the health of tumor tissue, " Opt. Lett. 29(1), 68-70 (2004).
21. K. Jeong, L. Peng, J. J. Turek, M. R. Melloch, and D. D. Nolte, "Fourier-domain holographic optical coherence imaging of tumor spheroids and mouse eye, " Appl. Opt. 44(10), 1798-1805 (2005).
22. K. Jeong, J. J. Turek, and D. D. Nolte, "Fourier-domain digital holographic optical coherence imaging of living tissue, " Appl. Opt. 46(22), 4999-5008 (2007).
23. P. Yu, M. Mustata, L. Peng, J. J. Turek, M. R. Melloch, P. M. French, and D. D. Nolte, "Holographic optical coherence imaging of rat osteogenic sarcoma tumor spheroids, " Appl. Opt. 43(25), 4862-4873 (2004).
24. A. Dubois, K. Grieve, G. Moneron, R. Lecaque, L. Vabre, and C. Boccara, "Ultrahigh-resolution full-field optical coherence tomography, " Appl. Opt. 43(14), 2874-2883 (2004).
25. M. Laubscher, M. Ducros, B. Karamata, T. Lasser, and R. Salathe, "Video-rate three-dimensional optical coherence tomography, " Opt. Express 10(9), 429-435 (2002).
26. Z. Yaqoob, J. Fingler, X. Heng, and C. H. Yang, "Homodyne en face optical coherence tomography, " Opt. Lett. 31(12), 1815-1817 (2006).
27. A. F. Fercher, W. Drexler, C. K. Hitzenberger, and T. Lasser, "Optical coherence tomography-principles and applications, " Rep. Prog. Phys. 66(2), 239-303 (2003).
28. D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, C. A. Puliafito, and J. G. Fujimoto, "Optical coherence tomography, " Science 254(5035), 1178-1181 (1991).
29. A. M. Al-Abd, J.-H. Lee, S. Y. Kim, N. Kun, and H.-J. Kuh, "Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel, " Cancer Sci. 99(2), 423-431 (2008).
30. M.-S. Choi, S.-H. Kim, and H.-J. Kuh, "Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells, " Oncol. Rep. 25(3), 863-870 (2011).
31. J. Friedrich, C. Seidel, R. Ebner, and L. A. Kunz-Schughart, "Spheroid-based drug screen: considerations and practical approach, " Nat. Protoc. 4(3), 309-324 (2009).
32. L. A. Kunz-Schughart, J. P. Freyer, F. Hofstaedter, and R. Ebner, "The use of 3-D cultures for high-throughput screening: the multicellular spheroid model, " J. Biomol. Screen. 9(4), 273-285 (2004).
33. J. Lee, M. J. Cuddihy, and N. A. Kotov, "Three-dimensional cell culture matrices: state of the art, " Tissue Eng. Part B Rev. 14(1), 61-86 (2008).
34. S. L. Voytik-Harbin, "Three-dimensional extracellular matrix substrates for cell culture, " Methods Cell Biol. 63, 561-581 (2001).
35. W. E. Moerner and D. P. Fromm, "Methods of single-molecule fluorescence spectroscopy and microscopy, " Rev. Sci. Instrum. 74(8), 3597-3619 (2003).
36. R. H. Webb, "Confocal optical microscopy, " Rep. Prog. Phys. 59(3), 427-471 (1996).
37. M. D. Cahalan, I. Parker, S. H. Wei, and M. J. Miller, "Two-photon tissue imaging: seeing the immune system in a fresh light, " Nat. Rev. Immunol. 2(11), 872-880 (2002).
38. K. König, "Multiphoton microscopy in life sciences, " J. Microsc. 200(2), 83-104 (2000).
39. J. Sharpe, U. Ahlgren, P. Perry, B. Hill, A. Ross, J. Hecksher-Sørensen, R. Baldock, and D. Davidson, "Optical projection tomography as a tool for 3D microscopy and gene expression studies, " Science 296(5567), 541-545 (2002).
40. J. Huisken, J. Swoger, F. Del Bene, J. Wittbrodt, and E. H. K. Stelzer, "Optical sectioning deep inside live embryos by selective plane illumination microscopy, " Science 305(5686), 1007-1009 (2004).
41. F. Hirschhaeuser, H. Menne, C. Dittfeld, J. West, W. Mueller-Klieser, and L. A. Kunz-Schughart, "Multicellular tumor spheroids: an underestimated tool is catching up again, " J. Biotechnol. 148(1), 3-15 (2010).
42. L. R. Bérubé, K. Harasiewicz, F. S. Foster, E. Dobrowsky, M. D. Sherar, and A. M. Rauth, "Use of a high frequency ultrasound microscope to image the action of 2-nitroimidazoles in multicellular spheroids, " Br. J. Cancer 65(5), 633-640 (1992).
43. M. D. Sherar, M. B. Noss, and F. S. Foster, "Ultrasound backscatter microscopy images the internal structure of living tumour spheroids, " Nature 330(6147), 493-495 (1987).
44. D. D. Nolte, R. An, J. Turek, and K. Jeong, "Tissue dynamics spectroscopy for three-dimensional tissue-based drug screening, " J Lab Autom 16(6), 431-442 (2011).
45. F. C. MacKintosh and S. John, "Diffusing-wave spectroscopy and multiple scattering of light in correlated random media, " Phys. Rev. B Condens. Matter 40(4), 2383-2406 (1989).
46. D. J. Pine, D. A. Weitz, P. M. Chaikin, and E. Herbolzheimer, "Diffusing wave spectroscopy, " Phys. Rev. Lett. 60(12), 1134-1137 (1988).
47. T. Katsuda and T. Maruyama, "Chemical-Kinetics Model for the Growth of a Multicellular Tumor Spheroid, " J. Chem. Eng. of Jpn 42(3), 198-203 (2009).
48. R. Venkatasubramanian, M. A. Henson, and N. S. Forbes, "Incorporating energy metabolism into a growth model of multicellular tumor spheroids, " J. Theor. Biol. 242(2), 440-453 (2006).
49. S. Rodríguez-Enríquez, J. C. Gallardo-Pérez, A. Avilés-Salas, A. Marín-Hernández, L. Carreño-Fuentes, V. Maldonado-Lagunas, and R. Moreno-Sánchez, "Energy metabolism transition in multi-cellular human tumor spheroids, " J. Cell. Physiol. 216(1), 189-197 (2008).
50. J. P. Freyer and R. M. Sutherland, "Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply, " Cancer Res. 46(7), 3504-3512 (1986).
51. K. Groebe and W. Mueller-Klieser, "On the relation between size of necrosis and diameter of tumor spheroids, " Int. J. Radiat. Oncol. Biol. Phys. 34(2), 395-401 (1996).
52. M. J. Tindall and C. P. Please, "Modelling the cell cycle and cell movement in multicellular tumour spheroids, " Bull. Math. Biol. 69(4), 1147-1165 (2007).
53. R. J. Gillies and R. A. Gatenby, "Hypoxia and adaptive landscapes in the evolution of carcinogenesis, " Cancer Metastasis Rev. 26(2), 311-317 (2007).
54. J. Zhou, T. Schmid, S. Schnitzer, and B. Brüne, "Tumor hypoxia and cancer progression, " Cancer Lett. 237(1), 10-21 (2006).
55. L. I. Cardenas-Navia, R. A. Richardson, and M. W. Dewhirst, "Targeting the molecular effects of a hypoxic tumor microenvironment, " Front. Biosci. 12(8-12), 4061-4078 (2007).
56. P. Hargrave, P. W. Nicholson, D. T. Delpy, and M. Firbank, "Optical properties of multicellular tumour spheroids, " Phys. Med. Biol. 41(6), 1067-1072 (1996).
57. J. R. Mourant, T. M. Johnson, V. Doddi, and J. P. Freyer, "Angular dependent light scattering from multicellular spheroids, " J. Biomed. Opt. 7(1), 93-99 (2002).
58. D. D. Nolte, K. Jeong, P. M. W. French, and J. J. Turek, "Holographic optical coherence imaging, " in Optical Coherence Tomography: Technology and Applications, J. F. A. W. Drexler, ed. (Springer Verlag, 2008).
59. D. D. Nolte, R. An, J. Turek, and K. Jeong, "Holographic tissue dynamics spectroscopy, " J. Biomed. Opt. 16(8), 087004 (2011).
60. E. Ifeachor and B. Jervis, Digital Signal Processing: a Practical Approach (Prentice Hall, 2001).
61. R. A. Johnson, Applied Multivariate Statistical Analysis (Prentice Hall, 2001).
62. B. Andreopoulos, A. J. An, X. G. Wang, and M. Schroeder, "A roadmap of clustering algorithms: finding a match for a biomedical application, " Brief. Bioinform. 10(3), 297-314 (2009).
63. T. A. Lampert and S. E. M. O'Keefe, "A survey of spectrogram track detection algorithms, " Appl. Acoust. 71(2), 87-100 (2010).
64. W. Fayad, L. Rickardson, C. Haglund, M. H. Olofsson, P. D'Arcy, R. Larsson, S. Linder, and M. Fryknäs, "Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties, " Chem. Biol. Drug Des. 78(4), 547-557 (2011).
65. H. R. Mellor, D. J. P. Ferguson, and R. Callaghan, "A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs, " Br. J. Cancer 93(3), 302-309 (2005).
66. M. A. Vooijs, E. H. Gort, A. J. Groot, E. der Wall, and P. J. van Diest, "Hypoxic regulation of metastasis via hypoxia-inducible factors, " Curr. Mol. Med. 8(1), 60-67 (2008).
67. M. W. Klymkowsky and P. Savagner, "Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe, " Am. J. Pathol. 174(5), 1588-1593 (2009).
68. R. Sullivan and C. H. Graham, "Hypoxia-driven selection of the metastatic phenotype, " Cancer Metastasis Rev. 26(2), 319-331 (2007).
69. W. Yan, Y. Fu, D. Tian, J. Z. Liao, M. Liu, B. Wang, L. M. Xia, Q. Zhu, and M. Luo, "PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells, " Biochem. Biophys. Res. Commun. 382(3), 631-636 (2009).
70. G. Farhat, A. Mariampillai, V. X. D. Yang, G. J. Czarnota, and M. C. Kolios, "Detecting apoptosis using dynamic light scattering with optical coherence tomography, " J. Biomed. Opt. 16(7), 070505 (2011).
71. E. Poon, A. L. Harris, and M. Ashcroft, "Targeting the hypoxia-inducible factor (HIF) pathway in cancer, " Expert Rev. Mol. Med. 11, e26 (2009).